While Latin America is known as an endemic area, there have been relatively few studies investigating the prevalence of Chagas disease in the Rio Grande Valley of Texas.
A paper published in PLOS Neglected Diseases led by researchers at the National School of Tropical Medicine at Baylor College of Medicine suggests that the disease burden in southern Texas is much higher than previously thought. Considering up to 30% of people infected with Trypanosoma cruzi can develop fatal cardiomyopathy, this study's findings carry important implications to the health of the population of south Texas.
In order to assess the infection status of vectors and seroprevalence among human and mammal populations living in in the lower Rio Grande Valley, Dr. Melissa Nolan Garcia, instructor of pediatrics at Baylor who is also with Texas Children's Hospital, and colleagues tested kissing bug vectors and retrospectively analyzed previously collected sera from coyotes, stray dogs, and human participants.
Out of 841 human sera samples, three people (0,4%) tested positive for T. cruzi, while 8% of coyotes and 3.8% of stray dogs were found to be infected. Among the insects sampled, 56.5% were found to be T. cruzi carriers.
Based on the findings of the study, the authors estimate that around 4,600 people in the Rio Grande Valley are currently infected with Chagas disease, and of those, an estimated 1,300 are at risk for developing cardiomyopathy. These results not only confirm the risk for disease transmission in south Texas, but indicate that the regional burden of Chagas disease is 23 times higher than previously estimated.
The study does have limitations, as the authors acknowledge that the specimens were originally collected for other studies, and they are now conducting larger, more extensive surveillance studies targeting Chagas risk in this region. Overall, the findings point to a greater need for attention to Chagas disease in United States, particularly the identification of high risk groups.
The authors assert that, "with up to 30% of infected individuals developing a potentially fatal cardiac disease, it is imperative that we identify and treat patients before heart disease occurs."
- » News Central
- » Popular News
- » Latest Health News
- » News Category A-Z (500+)
- » Health News and Press Release
- » News Archive
- » News Photo Gallery
- » Lifestyle and Wellness
- » Health Watch
- » Health In Focus
- » Celebrating Life
- » Breaking Health News
- » News From Other Resources
- » India Special
- » News Video Gallery
- » Medindia Exclusive - Interviews and In depth Reports